Phlo

Founded 2019
Employees 50+
Primary contact
147 Bath Street
G2 4SN Glasgow
Scotland
United Kingdom
Phlo provides a UK digital pharmacy, offering a same-day NHS and private prescription delivery service to patients in Birmingham and London, and launching in Manchester in 2023. The company's second product, Phlo Connect, provides digital pharmacy infrastructure that enables healthtech companies and private healthcare providers to offer a seamless digital pharmacy service.
Select partners: Babylon, Leva Clinic, SkinDoc, Syrona Health, The Dermatology Partnership.
Founded 2019
Employees 50+
Primary contact
147 Bath Street
G2 4SN Glasgow
Scotland
United Kingdom

Funding πŸ’°

Total Β£16.7M
Last round πŸ”— Β£10M
Series A
February 2, 2023.
Select investors Thairm Bio, Scottish Enterprise, Future Fund, Crowdcube, DigitalHealth.London

Key people πŸ§‘β€πŸ€β€πŸ§‘

Highlights ⭐

  • Fast growth: As of February 2023, over 110,000 orders have been delivered since the platform's launch in 2020, with user numbers more than doubling year-on-year.
  • Patients like it: 92% rate Phlo's service as "Excellent," 96% of patients find Phlo easy to use,a nd 93% agree that Phlo has saved them time and effort when getting their prescriptions. πŸ”—
  • Acquired a company: In April 2023, Phlo acquired the UK arm of US-based unicorn Truepill. As part of the acquisition, Phlo scooped up Truepill's partnerships with several UK digital healthcare providers such as The Lowdown, Levels, Daye, Hanx, and Veri as well as the company's tech stack including the full set of APIs and prescribing technology. πŸ”—

Video ▢️

Quotes πŸ’¬

Phlo's drive and determination to improve patient access and healthcare outcomes at this pivotal moment for the pharmacy sector is impressive. Phlo's dedication to building innovative digital solutions that put patients and clinicians at the heart of what they do is key to driving positive change in the sector, empowering patients and healthcare providers.
Mark Bamforth, founder of Thairm Bio
Last update: April 28, 2023